Skip to main content

Table 2 Underlying liver diseases (n = 144 patients)

From: Model of end stage liver disease (MELD) score greater than 23 predicts length of stay in the ICU but not mortality in liver transplant recipients

HCV liver cirrhoses overall

54 (37.5%)

HCV liver cirrhoses + HCC

20 (13.9%)

HBV liver cirrhoses overall

16 (11.1%)

HBV liver cirrhoses +HCC

7 (4.9%)

HCC overall

41 (28.5)

Alcoholic liver cirrhosis overall

24 (16.7%)

Alcoholic liver cirrhosis + HCC

1 (0.7%)

Alcoholic liver cirrhosis + HBV

1 (0.7%)

Acute liver failure

12 (8.3%)

PSC

5 (3.5%)

PBC

4 (2.8%)

Morbus Wilson

4 (2.8%)

Cryptogenic liver cirrhosis

2 (1.4%)

Amyloidosis

3 (2.1%)

Budd chiari syndrome

2 (1.4%)

Alpha-1-antitrypsin deficiency

1 (0.7%)

AIH liver cirrhosis

1 (0.7%)

Polycyclic liver disease

1 (0.7%)

Hyperoxalurie

1 (0.7%)

Vanishing bile duct syndrome

1 (0.7%)

M. Osler

1 (0.7%)

  1. AIH, autoimmune hepatitis; HBV, hepatitis B virus; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; PBC, primary biliary cirrhosis; PSC, primary sclerosing cholangitis.